Related references
Note: Only part of the references are listed.Resistance to Molecularly Targeted Therapies in Melanoma
Meet Patel et al.
CANCERS (2021)
Development of Pin1 Inhibitors and their Potential as Therapeutic Agents
Yusuke Nakatsu et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Indomethacin and juglone inhibit inflammatory molecules to induce apoptosis in colon cancer cells
Alagesan Seetha et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2020)
Juglone potentiates BRAF inhibitor-induced apoptosis in melanoma through reactive oxygen species and the p38-p53 pathway
Zheng Li et al.
MOLECULAR MEDICINE REPORTS (2020)
Cytotoxicity of juglone and thymoquinone against pancreatic cancer cells
Namrata Karki et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Targeted juglone blocks the invasion and metastasis of HPV-positive cervical cancer cells
Xingyu Zhao et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Synthesis, characterization and antibacterial activity of juglone encapsulated PLGA nanoparticles
T. Arasoglu et al.
JOURNAL OF APPLIED MICROBIOLOGY (2017)
Juglone potentiates TRAIL-induced apoptosis in human melanoma cells via activating the ROS-p38-p53 pathway
Xiao Liu et al.
MOLECULAR MEDICINE REPORTS (2017)
Loss of Pin1 Suppresses Hedgehog-Driven Medulloblastoma Tumorigenesis1
Tao Xu et al.
NEOPLASIA (2017)
Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling
F. Kruiswijk et al.
ONCOGENE (2016)
The role of Pin1 in the development and treatment of cancer
Sang-Hyun Min et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Imaging the microenvironment of pancreatic cancer patient-derived orthotopic xenografts (PDOX) growing in transgenic nude mice expressing GFP, RFP, or CFP
Robert M. Hoffman et al.
CANCER LETTERS (2016)
Nanoparticle systems reduce systemic toxicity in cancer treatment
Hai Wang et al.
NANOMEDICINE (2016)
Advances in the use of nanocarriers for cancer diagnosis and treatment
Debora Braga Vieira et al.
EINSTEIN-SAO PAULO (2016)
Nanoparticulate immunotherapy for cancer
Chintan H. Kapadia et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Pin1: A molecular orchestrator in the heart
Nirmala Hariharan et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2014)
RNA-interference-mediated downregulation of Pin1 suppresses tumorigenicity of malignant melanoma A375 cells
J. Jin et al.
NEOPLASMA (2013)
Evaluation of Pharmacokinetic, Biodistribution, Pharmacodynamic, and Toxicity Profile of Free Juglone and Its Sterically Stabilized Liposomes
B. Kiran Aithal et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
DNA REPAIR Cyclin D1 multitasks
Jiri Bartek et al.
NATURE (2011)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Biodegradable nanoparticles for cytosolic delivery of therapeutics
Jaspreet K. Vasir et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes
YC Liou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription
SH Chao et al.
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
